282
Views
7
CrossRef citations to date
0
Altmetric
Expert Opinion

Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations

ORCID Icon, ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 1267-1275 | Published online: 31 Oct 2019

References

  • Koberlein J, Vent J, Mosges R. On the sustainability of guideline implementation. World Allergy Organ J. 2010;3:258–261. doi:10.1097/WOX.0b013e3181fdfc7a23282944
  • Kulthanan K, Chusakul S, Recto MT, et al. Economic burden of the inadequate management of allergic rhinitis and urticaria in Asian countries based on the GA(2)LEN model. Allergy Asthma Immunol Res. 2018;10:370–378. doi:10.4168/aair.2018.10.4.37029949833
  • Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011;128:1139–50 e4. doi:10.1016/j.jaci.2011.09.00522035879
  • Davila I, Del Cuvillo A, Mullol J, et al. Use of second generation H1 antihistamines in special situations. J Investig Allergol Clin Immunol. 2013;23(Suppl 1):1–16.
  • Prepageran N, Wang de Y, Nair G, Maurer M. The status quo and unmet needs in the management of allergic rhinitis and chronic rhinosinusitis: a Malaysian perspective. Asia Pac Allergy. 2014;4:142–148. doi:10.5415/apallergy.2014.4.3.14225097849
  • Fitzsimons R, van der Poel LA, Thornhill W, du Toit G, Shah N, Brough HA. Antihistamine use in children. Arch Dis Child Educ Pract Ed. 2015;100:122–131. doi:10.1136/archdischild-2013-30444625147323
  • Kar S, Krishnan A, Preetha K, Mohankar A. A review of antihistamines used during pregnancy. J Pharmacol Pharmacother. 2012;3:105–108. doi:10.4103/0976-500X.9550322629082
  • Kay GG, Quig ME. Impact of sedating antihistamines on safety and productivity. Allergy Asthma Proc. 2001;22:281–283.11715216
  • Kuna P, Jurkiewicz D, Czarnecka-Operacz MM, et al. The role and choice criteria of antihistamines in allergy management – expert opinion. Postepy Dermatol Alergol. 2016;33:397–410. doi:10.5114/pdia.2016.6394228035215
  • McCue JD. Safety of antihistamines in the treatment of allergic rhinitis in elderly patients. Arch Fam Med. 1996;5:464–468.8797551
  • Yang HJ, Kim YH, Lee B, et al. Unmet primary physicians’ needs for allergic rhinitis care in Korea. Allergy Asthma Immunol Res. 2017;9:265–271. doi:10.4168/aair.2017.9.3.26528293933
  • Scadding GK, Williams A. The burden of allergic rhinitis as reported by UK patients compared with their doctors. Rhinology. 2008;46:99–106.18575009
  • Recto MT, Gabriel MT, Kulthanan K, et al. Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clin Mol Allergy. 2017;15:19. doi:10.1186/s12948-017-0074-329118675
  • Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8–160. doi:10.1111/j.1398-9995.2007.01620.x18331513
  • Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393–1414. doi:10.1111/all.1339729336054
  • Del Cuvillo A, Sastre J, Montoro J, et al. Use of antihistamines in pediatrics. J Investig Allergol Clin Immunol. 2007;17(Suppl 2):28–40.
  • Bayer Healthcare. Clarityne® Tablet & Syrup. 2015.
  • GlaxoSmithKline Pharmaceutical Sdn Bhd. ZYRTEC FILM-COATED TABLET/ORAL SOLUTION/ORAL DROPS. Cetirizine dihydrochloride (10mg, 1mg/mL, 10mg/mL). 2018.
  • HOE Pharmaceuticals Sdn. Bhd. ZORALIX 5 SF ELIXIR 5MG/5ML. 2014.
  • Kotra Pharma (M) Sdn. Bhd. AXCEL® CHLORPHENIRAMINE SYRUP.
  • Merck Sharp & Dohme (Malaysia) Sdn.Bhd. AERIUS® SYRUP. Desloratadine 0.5 mg/mL. 2018.
  • Sanofi-aventis (Malaysia) Sdn. Bhd. TELFAST® ORAL SUSPENSION. Fexofenadine hydrochloride (30mg/5ml). 2017.
  • Sunward Pharmaceutical Sdn. Bhd. POLARAX TABLET/SYRUP [AMENDED DRAFT PACKAGE INSERT]. 2019.
  • Upha Pharmaceutical Mfg. (M) Sdn. Bhd. CHLORAMINE SYRUP. 2016.
  • Xepa-Soul Pattinson (Malaysia) Sdn Bhd. Antamin™ Syrup. 2017.
  • Chainani E, Godse K, Agarwal S, Patil S. Knowledge and attitude of medical resident doctors toward antihistamines. Indian J Dermatol. 2015;60:635. doi:10.4103/0019-5154.169141
  • Simons FE, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008;1:145–155. doi:10.1186/s40413-018-0188-123282578
  • Randall KL, Hawkins CA. Antihistamines and allergy. Aust Prescr. 2018;41:41–45. doi:10.18773/austprescr.2018.01329670310
  • Vuurman EF, van Veggel LM, Uiterwijk MM, Leutner D, O’Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy. 1993;71:121–126.8346863
  • Blaiss MS and Allergic Rhinitis in Schoolchildren Consensus G. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin. 2004;20:1937–1952. doi:10.1185/030079904x1326615704310
  • Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol. 2000;105:S622–S627. doi:10.1067/mai.2000.10615310856168
  • Church MK, Maurer M, Simons FE, et al. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy. 2010;65:459–466. doi:10.1111/j.1398-9995.2009.02325.x20146728
  • Yang YH, Lin YT, Lu MY, Tsai MJ, Chiang BL. A double-blind, placebo-controlled, and randomized study of loratadine (Clarityne) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years. Asian Pac J Allergy Immunol. 2001;19:171–175.11826911
  • Garavello W, Romagnoli M, Sordo L, Gaini RM, Di Berardino C, Angrisano A. Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatr Allergy Immunol. 2003;14:140–143.12675761
  • Batchelor HK, Marriott JF. Formulations for children: problems and solutions. Br J Clin Pharmacol. 2015;79:405–418. doi:10.1111/bcp.1226825855822
  • Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol. 2005;59:674–676. doi:10.1111/j.1365-2125.2005.02410.x15948931
  • Banfield C, Gupta S, Marino M, Lim J, Affrime M. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine. Clin Pharmacokinet. 2002;41:311–318. doi:10.2165/00003088-200241040-0000411978146
  • Sadaba B, Azanza JR, Gomez-Guiu A, Rodil R. Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria. Ther Clin Risk Manag. 2013;9:197–205. doi:10.2147/TCRM.S1607923667312
  • Bailey DG. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol. 2010;70:645–655. doi:10.1111/j.1365-2125.2010.03722.x21039758
  • Meltzer EO, Blaiss MS, Naclerio RM, et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012;33(Suppl 1):S113–S141. doi:10.2500/aap.2012.33.360322981425
  • Yun J, Katelaris CH, Weerasinghe A, Adikari DB, Ratnayake C. Impact of chronic urticaria on the quality of life in Australian and Sri Lankan populations. Asia Pac Allergy. 2011;1:25–29. doi:10.5415/apallergy.2011.1.1.2522053293
  • Kay GG, Berman B, Mockoviak SH, et al. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Arch Intern Med. 1997;157:2350–2356.9361576
  • Wilken JA, Berkowitz R, Kane R. Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol. 2002;89:372–380. doi:10.1016/S1081-1206(10)62038-812392381
  • Simons FE, Fraser TG, Reggin JD, Simons KJ. Comparison of the central nervous system effects produced by six H1-receptor antagonists. Clin Exp Allergy. 1996;26:1092–1097.8889266
  • Guide for Aviation Medical Examiners: pharmaceuticals (Therapeutic Medications) do not Issue – do not Fly. Available from: https://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/pharm/dni_dnf/ Accessed 64, 2019.
  • Staevska M, Gugutkova M, Lazarova C, et al. Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol. 2014;171:148–154. doi:10.1111/bjd.1284624472058
  • Herman D, Arnaud A, Dry J, et al. [Clinical effectiveness and tolerance of loratadine versus cetirizine in the treatment of seasonal allergic rhinitis]. Allerg Immunol (Paris). 1992;24:270–274.1388662
  • Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with “non-sedating” antihistamines: four prescription-event monitoring studies in general practice. BMJ. 2000;320:1184–1186. doi:10.1136/bmj.320.7243.118410784544
  • Salmun LM, Gates D, Scharf M, Greiding L, Ramon F, Heithoff K. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday. Clin Ther. 2000;22:573–582. doi:10.1016/S0149-2918(00)80045-410868555
  • Ramaekers JG, Uiterwijk MM, O’Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42:363–369. doi:10.1007/bf002801191355427
  • Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge. Ann Allergy Asthma Immunol. 2000;84:451–459. doi:10.1016/S1081-1206(10)62280-610795655
  • Kaiser HB, Banov CH, Berkowitz RR, et al. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis. Am J Ther. 1998;5:245–251.10099066
  • Lockey RF. Rhinitis medicamentosa and the stuffy nose. J Allergy Clin Immunol. 2006;118:1017–1018. doi:10.1016/j.jaci.2006.06.01817088123
  • Mortuaire G, de Gabory L, Francois M, et al. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130:137–144. doi:10.1016/j.anorl.2012.09.00523375990
  • Aaronson DW. Side effects of rhinitis medications. J Allergy Clin Immunol. 1998;101:S379–S382. doi:10.1016/s0091-6749(98)70225-89500733
  • Deckx L, De Sutter AI, Guo L, Mir NA, van Driel ML. Nasal decongestants in monotherapy for the common cold. Cochrane Database Syst Rev. 2016;10:CD009612.27748955
  • Thomas J, Pandhi RK, Oberoi C, et al. A multicentric trial of loratadine and cetirizine in urticaria. Indian J Dermatol Venereol Leprol. 1998;64:12–16.20921702
  • Zuberbier T, Munzberger C, Haustein U, et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology. 1996;193:324–327. doi:10.1159/0002462818993958
  • World Health Organization. Reproductive Health and Research. Reproductive Health Indicators: Guidelines for Their Generation, Interpretation and Analysis for Global Monitoring. Geneva: World Health Organization; 2006.
  • Mehta N, Chen K, Powrie RO. Prescribing for the pregnant patient. Cleve Clin J Med. 2014;81:367–372. doi:10.3949/ccjm.81a.1312424891538
  • Gonzalez-Estrada A, Geraci SA. Allergy medications during pregnancy. Am J Med Sci. 2016;352:326–331. doi:10.1016/j.amjms.2016.05.03027650241
  • Ban GY, Kim MY, Yoo HS, et al. Clinical features of elderly chronic urticaria. Korean J Intern Med. 2014;29:800–806. doi:10.3904/kjim.2014.29.6.80025378979
  • Chuamanochan M, Kulthanan K, Tuchinda P, Chularojanamontri L, Nuchkull P. Clinical features of chronic urticaria in aging population. Asian Pac J Allergy Immunol. 2016;34:201–205. doi:10.12932/AP070827001657
  • Song WJ, Chang YS. Respiratory allergies in the elderly: findings from the Korean Longitudinal Study on Health and Aging phase I study (2005–2006). Asia Pac Allergy. 2017;7:185–192. doi:10.5415/apallergy.2017.7.4.18529094015
  • Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44:1055–1068. doi:10.1183/09031936.0005981425142482
  • Pinto JM, Jeswani S. Rhinitis in the geriatric population. Allergy Asthma Clin Immunol. 2010;6:10. doi:10.1186/1710-1492-6-1020465792
  • Slavin RG. Treating rhinitis in the older population: special considerations. Allergy Asthma Clin Immunol. 2009;5:9. doi:10.1186/1710-1492-5-920016692
  • Bowden T, Coiera E. The role and benefits of accessing primary care patient records during unscheduled care: a systematic review. BMC Med Inform Decis Mak. 2017;17:138. doi:10.1186/s12911-017-0523-428938900
  • Nyenhuis SM, Mathur SK. Rhinitis in older adults. Curr Allergy Asthma Rep. 2013;13:171–177. doi:10.1007/s11882-013-0342-323389558
  • Maeda T, Babazono A, Nishi T. Surveillance of first-generation H1-antihistamine use for older patients with dementia in Japan: a retrospective cohort study. Curr Gerontol Geriatr Res. 2018;2018:3406210. doi:10.1155/2018/340621030065759
  • Olasinska-Wisniewska A, Olasinski J, Grajek S. Cardiovascular safety of antihistamines. Postepy Dermatol Alergol. 2014;31:182–186. doi:10.5114/pdia.2014.4319125097491
  • Philpot EE. Safety of second generation antihistamines. Allergy Asthma Proc. 2000;21:15–20. doi:10.2500/10885410077824903310748947